ÂÜÀòÂÒÂ×

Simon Tulloch, BA MA BM BCh, Medicine, has over 15 years of experience in the pharmaceutical industry. From 2015 to present, they have served as Chief Medical Officer at Faraday Pharmaceuticals, Inc. From 2010 to 2015, they were the Owner/Principal Consultant at Capital Biopharma Consulting. From 2006 to 2010, they were the Chief Medical Officer at InfaCare Pharmaceuticals. From 2004 to 2006, they were the Senior Vice President, Business Unit Leader/CNS at Shire Pharmaceuticals, where they were responsible for ensuring strong collaboration between commercial and R&D organizations with significant focus upon P&L optimization and go-no recommendations for CNS pipeline progression through all R&D milestones and life-cycle investment decisions for portfolio of development and in-line marketed products. From 2000 to 2004, they were the Senior Vice President, US Research and Development at Shire Pharmaceuticals, where they were responsible for oversight of US R&D and Medical Affairs organizations focused upon pediatric and specialty care products across multiple therapy areas including CNS, GI, Oncology, Renal and Orphan Disorders.

Simon Tulloch graduated from the University of Oxford in 1982 with a BA MA BM BCh in Medicine.